Michael J. Overman

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Michael J. Overman

Dec 27, 2024, 11:06 | Insight

MD Anderson Cancer Center’s Research Highlights

The University of Texas showcases the latest breakthroughs in cancer care, research and prevention. These…

Dec 16, 2024, 18:57 | Insight

Next generation sequencing-based MSI scoring predict benefit in dMMR tumors treated with nivolumab

María Natalia Gandur Quiroga shared a post on X: "NGS-Based MSI Scoring Predicts Nivolumab Benefit…

Dec 16, 2024, 08:08 | Insight

Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared some…

Sep 5, 2024, 12:26 | Blog

How does pathologic response following neoadjuvant chemotherapy affect survival/recurrence in PCAD

Anirban Maitra shared on X: "Pathologic complete response following neoadjuvant chemotherapy in Pancreatic Cancer: Impact on…

All: 4 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023